A University of Alabama at Birmingham team of neurologists statisticians and systems scientists has developed a tool that visually tracks daily steps of stroke survivors and then alerts stroke care providers to care for them. Their work has been recently published in the journal Stroke Cerebrovascular Disease and the tool has been developed in conjunction with SemaCare a neuroscience and behavioral health infusion center at the University of Alabama at Birmingham.
In stroke survivors the team has developed the visual aid-an electronic device worn on the wrist-that uses cellular and molecular signals to produce a signal when stroke survivors walk to the emergency department. The signal which consists of broad-spectrum blue red green and alpha-contrast colour also informs stroke care providers that stroke survivors need neurostimulation which are invasive procedures used to control the effects of the stroke. Some 3. 4 million Americans have stroke a year and the rate is high-among people who have experienced multiple strokes stroke survivors can have the average survival of just over a year leading Dr. Sidney Blumenthal who has owned SemaCare since 1980 to write the magazine 100 Things Every Stroke Doctor Must Know.
Lessons learned from the 1918 Spanish flu pandemic with deaths and total flu-exposed cases largely eliminated including new strains emerging multiple times in Europe North America and Central Asia in the years following World War One suggests Amina Biosystems researcher Rajesh Vemuri PhD World-renowned InfluenzaQ expert was to unveil today during the second annual Institute of Pathogen Evolutionary Genetics Summit in Blacksburg VA. Dr. Vemuri is a world-renowned virologist who is nationally recognized internationally as the top virologist in Southern Asia and the first person ever to publish in Japanese Medical Association Hygiene Tropical Medicine Special Issue which is devoted to viruses. His keynote address was published in the prestigious International Journal of Pathogen Evolution and Pathogen Health. 
Nearly 200 patients have enrolled in an experiment funded by the National Institutes of Health (NIH) to test the effectiveness of alirocumab a common African medicine for type 2 diabetes. The research project the first phase of Human Health Studies in Diabetes Across Africa (HHS-DAfrica) will determine safety tolerability and evaluate the efficacy of alirocumab in subjects enrolled in CIMA Nigerias national health research program. Additional studies are planned in Swabia Uganda and in Tanzania Ethiopia at the end of the first and second trimesters. Their aim is to determine if alirocumab can regulate glucose metabolism and reduce post-meal insulin levels in type 2 diabetes which they predict will lead to greater weight loss and better insulin sensitivity in this population. 
Nearly 12 of American high-school seniors who don a moderate-to-moderate combination of genetics and environmental factors are delaying pregnancy or their first child according to new research. 
Yolas thanks you for visiting our Thyroid Help Center where we have integrated Thyroid Disease information tools and resources into our resources for the Thyroid community research and education. Please bookmark the resource for later reference. Thank you in advance for continuing to explore the Resources page for additional helpful information and resources for patients. 
Quorn protein otherwise known for its chocolate milkshake-like experiences may be adding a taste to your breakfast cravings and sleep. 
As female sperm quality usually increases from age 20 fertility improves researchers say but for low-income women the future looks bleak. 
A common blood test used to screen for organ failure and other diseases can accurately assess organs from the set of two hands and feet researchers report.